Age (years) |
62.4±10.1 |
61.2±11.4 |
63.9±8.3 |
0.2656 |
Male gender, n (%) |
48 (66.7%) |
27 (67.5%) |
21 (65.6%) |
0.9350 |
Arterial hypertension, n (%) |
44 (61.1%) |
25 (62.5%) |
19 (59.4%) |
0.9802 |
Diabetes mellitus, n (%) |
6 (8.3%) |
3 (7.5%) |
3 (9.4%) |
0.8894 |
Coronary artery disease, n (%) |
8 (11.1%) |
2 (5%) |
6 (18.8%) |
0.1408 |
Pacemaker or ICD, n(%) |
3 (4.2%) |
1 (2.5%) |
3 (9.4%) |
0.4522 |
Left ventricular ejection fraction < 45%, n (%) |
8 (11.1%) |
6 (15%) |
2 (6.3%) |
0.4300 |
Left atrial diameter (mm) |
43.7±2.7 |
43.7±2.8 |
43.8±2.6 |
0.8770 |
Left ventricular ejection fraction (%) |
52±5.5 |
51.5±4.7 |
52.7±6.5 |
0.3667 |
CHA2DS2-VASc score |
1.86±1.28 |
1.8±1.29 |
1.94±1.29 |
0.6487 |
Previous AF ablation, n(%) |
|
|
|
|
Total patients, n(%) |
37 (51.4%) |
9 (22.5%) |
28 (87.5%) |
<0.0001 |
Patients with 1 previous procedure, n(%) |
33 (45.8%) |
8 (20%) |
25
(78.1%) |
<0.0001 |
Patients with 2 previous procedures, n(%) |
4 (5.5%) |
1 (2.5%) |
3
(9.4%) |
0.4522 |
Type of AF at the time of MI ablation |
|
|
|
|
Persistent AF, n(%) |
21 (29.2%) |
21 (52.5%) |
0 |
- |
Long-standing persistent AF, n(%) |
16 (22.2%) |
16 (40%) |
0 |
- |
Paroxysmal AF, n(%) |
3 (4.2%) |
3 (7.5%) |
0 |
- |